- Home
- SRM vs ACXP Comparison
SRM vs ACXP Comparison
Compare SRM & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRM
- ACXP
- Stock Information
- Founded
- SRM 1979
- ACXP 2017
- Country
- SRM United States
- ACXP United States
- Employees
- SRM N/A
- ACXP N/A
- Industry
- SRM
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SRM
- ACXP Health Care
- Exchange
- SRM Nasdaq
- ACXP Nasdaq
- Market Cap
- SRM 9.0M
- ACXP 8.4M
- IPO Year
- SRM 2023
- ACXP 2021
- Fundamental
- Price
- SRM $7.93
- ACXP $0.49
- Analyst Decision
- SRM
- ACXP Strong Buy
- Analyst Count
- SRM 0
- ACXP 2
- Target Price
- SRM N/A
- ACXP $10.00
- AVG Volume (30 Days)
- SRM 20.8M
- ACXP 18.6M
- Earning Date
- SRM 08-11-2025
- ACXP 08-08-2025
- Dividend Yield
- SRM N/A
- ACXP N/A
- EPS Growth
- SRM N/A
- ACXP N/A
- EPS
- SRM N/A
- ACXP N/A
- Revenue
- SRM $4,394,659.00
- ACXP N/A
- Revenue This Year
- SRM N/A
- ACXP N/A
- Revenue Next Year
- SRM N/A
- ACXP N/A
- P/E Ratio
- SRM N/A
- ACXP N/A
- Revenue Growth
- SRM N/A
- ACXP N/A
- 52 Week Low
- SRM $0.26
- ACXP $0.30
- 52 Week High
- SRM $12.80
- ACXP $3.33
- Technical
- Relative Strength Index (RSI)
- SRM 61.58
- ACXP 51.70
- Support Level
- SRM $6.42
- ACXP $0.46
- Resistance Level
- SRM $8.85
- ACXP $0.56
- Average True Range (ATR)
- SRM 2.02
- ACXP 0.10
- MACD
- SRM -0.11
- ACXP -0.01
- Stochastic Oscillator
- SRM 54.11
- ACXP 25.55
About SRM SRM Entertainment Inc.
SRM Entertainment Inc is a trusted toy and souvenir designer and developer, selling into theme parks and entertainment venues. It has developed, manufactured, and supplied the entertainment and amusement park industry with exclusive products that are often only available to consumers inside SRM's customer base venues such as Walt Disney Parks and Resorts, Universal Studios, SeaWorld, Six Flags, Great Wolf Lodge, Dollywood, and Merlin Entertainment. Its product category includes The Smurfs and Zoonicorns, Sammy Sloth, lilita Llama, kyle Koala, and Hanna Hedgehog.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration. The company's approach is to develop antibiotic candidates with a Gram-positive selective spectrum. The Company's segment consists of the development of clinical and preclinical product candidates for the development of the Company's proprietary new therapies.